HALOPERIDOL-INDUCED HYPERAMMONEMIA IN A CHILD WITH CITRULLINEMIA

被引:5
|
作者
RUBENSTEIN, JLR
JOHNSTON, K
ELLIOTT, GR
BRUSILOW, SW
机构
[1] Stanford Department of Psychiatry S253, Stanford Medical Center, Stanford, 94305, CA
关键词
D O I
10.1007/BF01799580
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:754 / 755
页数:2
相关论文
共 50 条
  • [21] BROMOCRIPTINE IN THE TREATMENT OF HALOPERIDOL-INDUCED GALACTORRHEA
    VARIA, IM
    CAVENAR, JO
    TASKA, RJ
    MALTBIE, AA
    NORTH CAROLINA MEDICAL JOURNAL, 1982, 43 (11) : 769 - 770
  • [22] LEARNING IN TOLERANCE TO HALOPERIDOL-INDUCED CATALEPSY
    HINSON, RE
    POULOS, CX
    THOMAS, WL
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1982, 6 (4-6): : 395 - 398
  • [24] HALOPERIDOL-INDUCED LIVER-DISEASE
    FULLER, CM
    YASSINGER, S
    DONLON, P
    IMPERATO, TJ
    RUEBNER, B
    WESTERN JOURNAL OF MEDICINE, 1977, 127 (06): : 515 - 518
  • [25] Haloperidol-induced myoclonus in a patient with delirium
    Hayase, Tomomi
    Saiga, Hiroshi
    Yamaguchi, Takashi
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2023, 23 (03) : 243 - 244
  • [26] Modulating role of NO in haloperidol-induced catalepsy
    Narkevich, VB
    Mikoyan, VD
    Bashkatova, VG
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2005, 139 (03) : 328 - 330
  • [27] PREVENTION OF NEONATAL HYPERAMMONEMIA IN CITRULLINEMIA
    DONN, SM
    THOENE, JG
    WILSON, GN
    PEDIATRIC RESEARCH, 1985, 19 (04) : A247 - A247
  • [28] PREVENTION OF NEONATAL HYPERAMMONEMIA IN CITRULLINEMIA
    DONN, SM
    WILSON, GN
    THOENE, JG
    CLINICAL RESEARCH, 1984, 32 (04): : A806 - A806
  • [29] Brain tyrosine depletion attenuates haloperidol-induced striatal dopamine release in vivo and augments haloperidol-induced catalepsy in the rat
    Jaskiw, GE
    Bongiovanni, R
    PSYCHOPHARMACOLOGY, 2004, 172 (01) : 100 - 107
  • [30] Brain tyrosine depletion attenuates haloperidol-induced striatal dopamine release in vivo and augments haloperidol-induced catalepsy in the rat
    George E. Jaskiw
    Rodolfo Bongiovanni
    Psychopharmacology, 2004, 172 : 100 - 107